FRC
FRC Logo
Community
Sign InGet Access

Connect With Us

Stay updated with our latest research and insights

Fundamental Research Corp Logo

Highly ranked equity research firm providing institutional grade tools and analysis to all investors worldwide. Trusted by global investors for over 20+ years.

20+ Years
Rate us on TrustpilotLeave a review

Policies

  • Privacy Policy
  • Terms of Service
  • Disclaimer

Company

  • About Us
  • Our Team
  • Contact Us
  • Leave a Review

Resources

  • Videos
  • Research Reports
  • Community
  • FAQ
  • How to use the site

Browse

  • Stock Directory
  • Stock Screener
  • Market Intel Weekly
  • Report Archive

Trackers

  • Congress Trading
  • Senate Trading
  • Congress Net Worth
  • Markets

© 2026 Fundamental Research Corp. All Rights Reserved.

Professional investment research since 2003

Home
Strategies
Intel
Analysis
Community
Fund ProfileState Street SPDR S&P Pharmaceuticals ETF
  • Fund Overview
  • Fund Data
  • Peer Comparison
  • Ownership & News
XPH
State Street SPDR S&P Pharmaceuticals ETF ETF AnalysisComprehensive ETF analysis for State Street SPDR S&P Pharmaceuticals ETF (XPH) including NAV, expense ratio, dividend yield, sector breakdown, and holdings data.ETF AnalysisXPH
XPH
State Street SPDR S&P Pharmaceuticals ETF
  • Fund Overview
  • Fund Data
  • Peer Comparison
  • Ownership & News
XPH
  1. Home
  2. Screener
  3. State Street SPDR S&P Pharmaceuticals ETFXPHETF

State Street SPDR S&P Pharmaceuticals ETF

ETF
🇺🇸XPH•AMEX•Equity
Fund size (USD)
$516.35M
Expense Ratio
0.35%
Yield (12 mo)
0.43%
Holdings
61

Your view on XPH

State Street SPDR S&P Pharmaceuticals ETF

ETFSPDR
🇺🇸XPH•AMEX•Equity
Fund size (USD)
$516.35M
Expense Ratio
0.35%
Yield (12 mo)
0.43%
Holdings
61
Your view
Fund Overview

Overview

What the fund invests in, who runs it, and what it costs.

State Street SPDR S&P Pharmaceuticals ETF (XPH) is an Equity fund from SPDR, listed since 2006, with $516.4M in assets under management, a 0.35% expense ratio and a NAV of $67.94 USD.

Overview for State Street SPDR S&P Pharmaceuticals ETF

Fund Type
ETF
Fund Issuer
SPDR
Asset Class
Equity
Sector
Financial Services
Industry
Asset Management
Inception Date
June 19, 2006
Domicile
US
Website
ssga.com/us/en/institutional/etfs/state-street-spdr-sp-pharmaceuticals-etf-xph
Fund Type
ETF
Fund Issuer
SPDR
Asset Class
Equity
Sector
Financial Services
Industry
Asset Management
Inception Date
June 19, 2006
Domicile
US
Website
ssga.com/us/en/institutional/etfs/state-street-spdr-sp-pharmaceuticals-etf-xph
Fund Type
ETF
Fund Issuer
SPDR
Asset Class
Equity
Sector
Financial Services
Industry
Asset Management
Inception Date
June 19, 2006
Domicile
US
Website
ssga.com/us/en/institutional/etfs/state-street-spdr-sp-pharmaceuticals-etf-xph

About this fund

The State Street SPDR S&P Pharmaceuticals ETF seeks to provide investment results that, before fees and expenses, correspond generally to the total return performance of the S&P Pharmaceuticals Select Industry Index (the "Index")Seeks to provide exposure to the pharmaceuticals se…

Fund Data

Price Chart

Market price history and trading volume.

Key Facts

Cost, yield, size, and the fund's reference data.

Equity

Expense Ratio

0.35%

Yield (12 mo)

0.43%

Fund size

$516.35M

Fund Details

NAV$67.94 USD
Holdings61
Average Volume173.5K
Inception DateJune 19, 2006
Asset ClassEquity
Fund IssuerSPDR
DomicileUS
ISINUS78464A7220
CUSIP78464A722
NAV CurrencyUSD

Expense Ratio

0.35%

Dividend Yield (TTM)

0.43%

Assets Under Management

$516.35M

NAV

$67.94 USD

Holdings

61

Average Volume

173.5K

Inception Date

June 19, 2006

Asset Class

Equity

Fund Issuer

SPDR

Domicile

US

ISIN

US78464A7220

CUSIP

78464A722

NAV Currency

USD

Expense Ratio

0.35%

Dividend Yield (TTM)

0.43%

Assets Under Management

$516.35M

NAV

$67.94 USD

Holdings

61

Average Volume

173.5K

Inception Date

June 19, 2006

Asset Class

Equity

Fund Issuer

SPDR

Domicile

US

ISIN

US78464A7220

CUSIP

78464A722

NAV Currency

USD

Distributions · last 12 months

Quarterly · 4 payments

Ex-datePaidAmount
Sep 21, 2026Sep 23, 2026$0.0416
Jun 22, 2026Jun 24, 2026$0.059
Mar 23, 2026Mar 25, 2026$0.061
Dec 22, 2025Dec 24, 2025$0.113
Total, 12 months$0.27 a share

Dividend yield (TTM) 0.43% = $0.27 paid per share in the 12 months to Nov 20, 2026 ÷ the $64.23 price. Past distributions; future payments can differ.

Data last updated: Nov 12, 2026, 08:11 AM

Sectors

How the fund's assets are split across sectors.

1 sectors
  • 1Healthcare
    100.0%

Top sector

Healthcare

Top weight

100.0%

Top 3 weight

100.0%

Holdings

The securities the fund owns, by weight.

62 positions
1XERSXERIS BIOPHARMA HOLDINGS INC
4.63%
2MANEVERADERMICS INC
2.68%
3AMRXAMNEAL PHARMACEUTICALS INC
2.67%
4VTRSVIATRIS INC
2.59%
5LLYELI LILLY + CO
2.58%
6MAZEMAZE THERAPEUTICS INC
2.52%
7PRGOPERRIGO CO PLC
2.40%
8RPRXROYALTY PHARMA PLC CL A
2.40%
9ELANELANCO ANIMAL HEALTH INC
2.40%
10ZTSZOETIS INC
2.37%
11COLLCOLLEGIUM PHARMACEUTICAL INC
2.27%
12ETONETON PHARMACEUTICALS INC
2.24%
13PBHPRESTIGE CONSUMER HEALTHCARE
2.19%
14OGNORGANON + CO
2.19%
15JNJJOHNSON + JOHNSON
2.15%

Concentration

Top 10 Weight27.25%
1XERSXERIS BIOPHARMA HOLDINGS INC
4.63%
2MANEVERADERMICS INC
2.68%
3AMRXAMNEAL PHARMACEUTICALS INC
2.67%
4VTRSVIATRIS INC
2.59%
5LLYELI LILLY + CO
2.58%
6MAZEMAZE THERAPEUTICS INC
2.52%
7PRGOPERRIGO CO PLC
2.40%
8RPRXROYALTY PHARMA PLC CL A
2.40%
9ELANELANCO ANIMAL HEALTH INC
2.40%
10ZTSZOETIS INC
2.37%
11COLLCOLLEGIUM PHARMACEUTICAL INC
2.27%
12ETONETON PHARMACEUTICALS INC
2.24%
13PBHPRESTIGE CONSUMER HEALTHCARE
2.19%
14OGNORGANON + CO
2.19%
15JNJJOHNSON + JOHNSON
2.15%

Top 10 Weight

27.25%

1XERSXERIS BIOPHARMA HOLDINGS INC
4.63%$23.21M
2MANEVERADERMICS INC
2.68%$13.44M
3AMRXAMNEAL PHARMACEUTICALS INC
2.67%$13.35M
4VTRSVIATRIS INC
2.59%$12.97M
5LLYELI LILLY + CO
2.58%$12.94M
6MAZEMAZE THERAPEUTICS INC
2.52%$12.64M
7PRGOPERRIGO CO PLC
2.40%$12.04M
8RPRXROYALTY PHARMA PLC CL A
2.40%$12.04M
9ELANELANCO ANIMAL HEALTH INC
2.40%$12.02M
10ZTSZOETIS INC
2.37%$11.87M
11COLLCOLLEGIUM PHARMACEUTICAL INC
2.27%$11.35M
12ETONETON PHARMACEUTICALS INC
2.24%$11.23M
13PBHPRESTIGE CONSUMER HEALTHCARE
2.19%$10.97M
14OGNORGANON + CO
2.19%$10.96M
15JNJJOHNSON + JOHNSON
2.15%$10.77M

Top 10 Weight

27.25%

Peer Comparison

Comparables

Funds similar to this one.

Side by side on what an ETF is compared on19 funds
FundAsset classExpense ratioAssetsHoldings
XPHState Street SPDR S&P Pharmaceuticals ETFThis fundEquity0.35%$516M61

Comparable funds

  • BFORBarron's 400SM ETFEquity0.65%$238M1
  • DEUSXtrackers Russell US Multifactor ETFEquity0.17%$307M862
  • DFEWisdomTree Europe SmallCap Dividend FundInternational Equity0.58%$161M391
  • HSCZiShares Currency Hedged MSCI EAFE Small-Cap ETFEquity0.83%$259M1
  • SDGiShares MSCI Global Sustainable Development Goals ETFEquity0.50%$162M120
  • TBGTBG Dividend Focus ETFEquity0.45%$338M0
  • TURiShares MSCI Turkey ETFEquity0.59%$161M76
  • XESState Street SPDR S&P Oil & Gas Equipment & Services ETFEquity0.35%$265M35

More SPDR ETFs

  • WIPSPDR FTSE International Government Inflation-Protected Bond ETFFixed Income0.50%$462M234
  • WXHG.AXState Street SPDR S&P World ex Australia Carbon Aware (Hedged) ETFEquity0.10%$397M621
  • WXOZ.AXState Street SPDR S&P World ex Australia Carbon Aware ETFEquity0.07%$858M621
  • XARState Street SPDR S&P Aerospace & Defense ETFEquity0.35%$4.8B50
  • XBIState Street SPDR S&P Biotech ETFEquity0.35%$10.0B165
  • XCNYState Street SPDR S&P Emerging Markets ex-China ETFEquity0.19%$10M1,167
  • XHBState Street SPDR S&P Homebuilders ETFEquity0.35%$1.6B34
  • XHEState Street SPDR S&P Health Care Equipment ETFEquity0.35%$163M73
  • XHSState Street SPDR S&P Health Care Services ETFEquity0.35%$245M61
  • XITKState Street SPDR FactSet Innovative Technology ETFEquity0.45%$61M93
  • XLBState Street Materials Select Sector SPDR ETFEquity0.08%$8.4B24
Ownership & News

Fund Holders

Institutions that own shares of this fund.

News

Latest headlines and market coverage.

About this section

Latest headlines and company announcements for this company. Press releases and market coverage, newest first.